Spore.Bio Celebrates $23M Series A Funding for Real-World Impact
Deal News | Feb 20, 2025 | Localglobe
Localglobe, a prominent private equity firm, has announced a successful $23 million Series A funding round for Spore.Bio. This investment aims to enhance scientific discoveries by translating research into practical, real-world applications. Spore.Bio is set to use this infusion of capital to further its objectives in the scientific and technological spaces, an initiative that Localglobe is excited to support as it impacts a broad range of industries.
Sectors
- Biotechnology
- Private Equity
Geography
- United States – Spore.Bio's operations and impacts are likely focused in the United States.
- United Kingdom – Localglobe, the private equity firm, is based in the United Kingdom.
Industry
- Biotechnology – Spore.Bio operates within the biotechnology sector, emphasizing scientific discoveries and their applications.
- Private Equity – Localglobe, a private equity firm, facilitated the Series A funding round for Spore.Bio.
Financials
- $23 million – The amount raised by Spore.Bio in their Series A funding round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Spore.Bio | Target Company | Company | A company in the biotechnology sector receiving Series A funding. |
| Localglobe | Funding Company | Company | A UK-based private equity firm investing $23 million in Spore.Bio. |